WIBOFA - Validation of SCT02 With ECG-App for Detection of AF

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 373 participants.

Also called NCT06351761

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose basic science
Phase
Not applicable
Enrolled
  • 373 participants (enrolled count) (from the registry)
Sponsor
  • Withings Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06351761
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06351761. Non-randomized; no masking; primary purpose basic science. Start 2024-06-03 (actual); primary completion 2025-06-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
WIBOFA - Validation of SCT02 With ECG-App for Detection of AF
Acronym
WIBOFA
Intervention (Device)
Investigational Device (Withings SCT02) 30 second Electrocardiogram recording
Intervention (Device)
Reference Device (Schiller Cardiovit FT-1) 30 second Electrocardiogram recording
Lead sponsor
Withings (class: industry)

Record details

Record id
cardio:ct-nct06351761
Content hash
0d8a1b8fe93b9d6f01b5381f6073a2f0515c20edaf46b43cea17f52070fe0c4a